Search clinical trials for: SCH-58235

Total 2335 results

SCM Lifescience Co., LTD.

Completed

Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

Korea, Republic of
SCM Lifescience Co., LTD.

Completed

Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis

Pancreatitis, Acute

Korea, Republic of
Allium, Ltd.

Completed

Safety and Performance of the EndoFast Reliant SCP in Vaginal Wall Reinforcement

Pelvic Organ Prolapse
Centre Hospitalier Universitaire de Nice

Completed

Different Surgical Techniques Used for Prolapse Repair in Elderly Patient

Unrecognized Condition
Scynexis, Inc.

Completed

Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

Chronic Hepatitis C

United States
Universitätsklinikum Hamburg-Eppendorf

Completed

Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma

Multiple Myeloma | Stem Cell Transplantation
Boston Scientific Corporation

Completed

Randomized Study of Failed SCS Trials Comparing Outcomes Using the Observational Mechanical Gateway (OMG) Connector (RESCUE)

Chronic Pain

United States
Indivior Inc.

Completed

Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)

Drug Abuse | Opiate Dependence | Opiate-related Disorders
Indivior Inc.

Completed

A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)

Opiate Dependence | Drug Dependence
National Cancer Institute (NCI)

Completed

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer

Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

Hepatitis C, Chronic
Duke University
Schering-Plough

Completed

PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas

Glioblastoma | Gliosarcoma | Anaplastic Astrocytoma

United States
University of Michigan
The Craig H. Neilsen Foundation

Recruiting

Acceptance and Commitment Therapy for Chronic Pain in SCI: Development and Testing of an eHealth Program

Spinal Cord Injuries

United States
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN

C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and III

Netherlands, Australia, Belgium
Alexion Pharmaceuticals

Completed

A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)

C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease

United Kingdom, United States
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Different Forms of Danicopan (Tablet, Softgel Capsule, Liquid-filled Capsule) in Healthy Participants

Healthy

New Zealand
Boston Scientific Corporation

Completed

Safety and Effectiveness Study of the Precision SCS Systems Adapted for High-Rate Spinal Cord Stimulation (ACCELERATE)

Back Pain | Chronic Pain

United States
Children's Hospital Medical Center, Cincinnati

Completed

Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease (iTransition)

Sickle Cell Disease

United States
Organon and Co

Completed

A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524)

Asthma
Merck Sharp & Dohme LLC

Completed

Sugammadex Hypersensitivity Study (Study P06042)

Hypersensitivity
Alexion Pharmaceuticals

Completed

A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule in Healthy Adult Participants

Healthy

United States
Sinocelltech Ltd.

Unknown

SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Columbia University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Enhanced HIV Prevention in Couples: Feasibility Study #3 (EPIC)

Human Immunodeficiency Virus (HIV) | Acquired Immune Deficiency Syndrome (AIDS)

Lesotho
Emory University
National Cancer Institute (NCI); National Institutes of Health (NIH); Exelixis

Active, not recruiting

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IV Hypopharyngeal Squamous Cell Carcinoma... and other conditions

United States
Organon and Co

Completed

Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)

Rhinitis, Allergic
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Pembrolizumab in Treating Patients With Advanced Uveal Melanoma

Stage IV Uveal Melanoma | Stage IIIA Uveal Melanoma | Stage IIIB Uveal Melanoma | Stage IIIC Uveal Melanoma

United States
Merck Sharp & Dohme LLC
Quintiles, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Melanoma | Carcinoma, Non-Small-Cell Lung | Breast Neoplasm | Metastases of Central Nervous System
Merck Sharp & Dohme LLC

Completed

Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

Hepatitis C | Hepatitis C, Chronic
Emory University
National Center for Complementary and Integrative Health (NCCIH)

Recruiting

Development and Adaptation of I-STRONG for SCD

Sickle Cell Disease

United States
University Hospital, Ghent

Recruiting

Effectiveness of the Suicidal Crisis Intervention (SCI) (RCT SCI)

Suicidal Ideation | Suicide, Attempted | Suicide

Belgium
Hospital Universitario 12 de Octubre
University Hospital, Clermont-Ferrand; University Hospital, Grenoble; Technical... and other collaborators

Recruiting

BRAINI-2 Elderly Mild TBI European Study (BRAINI2ELDER)

Mild Traumatic Brain Injury

Spain, France, Germany
Nevro Corp

Recruiting

PDN Post Market, Multicenter, Prospective, Global Clinical Study (PDN-PM)

Diabetic Neuropathy, Painful

United States
Alexion

Completed

Study of ALXN2050 in Participants With Renal Impairment

Healthy | Renal Impairment

United States
Endo Pharmaceuticals

Completed

Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP

Edematous Fibrosclerotic Panniculopathy

United States
University of Alberta

Completed

Alberta Project Promoting Active Living and Healthy Eating in Schools (APPLE Schools)

Childhood Obesity

Canada
NYU Langone Health

Completed

Diabetes CKD Lifestyle Technology Study

Obesity | Diabetes | Chronic Kidney Disease

United States
Sir Mortimer B. Davis - Jewish General Hospital

Completed

The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer

Prostate Cancer

Canada
MedtronicNeuro

Completed

OPTIONS Spinal Cord Stimulation Programming Parameters

Pain, Intractable

United States
Wake Forest University Health Sciences

Not yet recruiting

Evaluating Spinal Cord Stimulation for Stiff Person Syndrome

Stiff-Person Syndrome

United States
Massachusetts General Hospital

Recruiting

Paresthesia Free Spinal Cord Stimulation (PF-SCS)

Chronic Pain | SCS

United States
Viz.ai, Inc.

Enrolling by invitation

ADVANCE- Automated Detection and Volumetric Assessment of ICH

Intracerebral Hemorrhage

United States
Kaohsiung Medical University Chung-Ho Memorial...

Completed

ACP Simulation-based Communication Training Program for Nurses Discussing ACP With Chronic Kidney Disease Patients

Chronic Kidney Diseases

Taiwan
Brigham and Women's Hospital

Completed

Multi-center Clinical Trial of Limiting Resident Work Hours on ICU Patient Safety (ROSTERS)

Physician Fatigue

United States
SciClone Pharmaceuticals

Unknown

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Oral Mucositis

United States
Danish Pain Research Center

Completed

Treatment With Spinal Cord Stimulation: Effect on Sensory Parameters

Chronic Pain

Denmark
SciClone Pharmaceuticals

Completed

Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer (SCV-07 OM)

Head and Neck Cancer | Oral Mucositis

United States
Abbott Medical Devices

Terminated

SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study (SENSE)

Low Back Pain | Failed Back Surgery Syndrome | Post-Laminectomy Syndrome

United States
Brigham and Women's Hospital
The Craig H. Neilsen Foundation

Recruiting

SCI-Lynx: A Mobile Platform for Physical Activity Social Support for People With SCI Pilot Study

Spinal Cord Injuries

United States
Abbott Medical Devices

Completed

Study of Gemini Rechargeable Spinal Cord Stimulation (SCS) System

Chronic Pain

Australia
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Completed

18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases

Brain Metastases

United States

Search clinical trials for: SCH-58235

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations